Hepatopathy following irradiation and adriamycin
- 1 July 1978
Abstract
This report describes two cases of hepatopathy following irradiation and adriamycin at doses and volumes of irradiation ordinarily considered within the tolerance of hepatic function. In one case fatal hepatopathy followed 2400 rad/17 fractions/28 days to the entire liver with preceding and concurrent adriamycin. In the second case moderate clinical changes occurred after treatment in which much of the right lobe of the liver was shielded following 2500 rad/23 fractions/32 days with adriamycin administered before, during, and after irradiation. The locally enhancing effects of adriamycin on hepatic tolerance to irradiation are discussed.This publication has 17 references indexed in Scilit:
- Adriamycin-irradiation cutaneous complicationsInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Adriamycin cardiotoxicityThe American Journal of Surgical Pathology, 1977
- Complications of irradiation related to apparent drug potentiation by adriamycinInternational Journal of Radiation Oncology*Biology*Physics, 1976
- Adriamycin and Enhanced Radiation Reaction in Normal Esophagus and SkinAnnals of Internal Medicine, 1976
- Quantification of combined radiation therapy and chemotherapy effects on critical normal tissuesCancer, 1976
- Radiation-adriamycin interactions: Preliminary clinical observationsCancer, 1975
- Modification of radiation injury to normal tissues by chemotherapeutic agentsCancer, 1975
- Adriamycin Cardiomyopathy: Enhanced Cardiac Damage in Rabbits with Combined Drug and Cardiac IrradiationRadiology, 1975
- A simplification in the use of the NSD concept in practical radiotherapyThe British Journal of Radiology, 1973
- Radiation Hepatitis: Possible Prevention by Combined Isotopic and External Radiation TherapyRadiology, 1968